Vascular Solutions (VASC) Tops Q3 EPS by 2c; Boosts FY15 Outlook

Vascular Solutions (NASDAQ: VASC) reported Q3 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $37 million versus the consensus estimate of $36.41 million.

Vascular Solutions sees FY2015 EPS of $1.03-$1.05, versus the consensus of $1.03. Vascular Solutions sees FY2015 revenue of $146-17 million, versus the consensus of $146.4 million.

For earnings history and earnings-related data on Vascular Solutions (VASC) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
• Pfizer lung cancer drug misses survival goal in Phase 3 trial